Polomar Health Services (PMHS) Interest Coverage Ratio (2023 - 2026)
Polomar Health Services (PMHS) posted Interest Coverage Ratio of 12.12 for Q2 2026, up 3344.04% on a QoQ basis from 0.37 in Q1 2026, and up 190.85% year-over-year from 4.17 in Q2 2025.
Powered by 
Analysis
Polomar Health Services (PMHS) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Polomar Health Services has reported Interest Coverage Ratio for 4 years, with the latest figure at 12.12 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio rose 190.85% year-over-year to 12.12 in Q2 2026; TTM through Jun 2026 was 90.3, a 488.13% decrease from a year earlier, with the FY2025 full-year figure at 69.94, down 125.18% from the prior year.
- Interest Coverage Ratio was 12.12 for Q2 2026 at Polomar Health Services, up from 0.37 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 12.12 in Q2 2026, with the low at 193.57 in Q4 2025.
- Average Interest Coverage Ratio over 4 years is 28.08, with a median of 11.68 recorded in 2025.
- The sharpest annual moves came in 2024 and 2026: Interest Coverage Ratio sank 1008.56% in 2024, then surged 190.85% in 2026.
- Over 4 years, Interest Coverage Ratio stood at 2.56 in 2023, then tumbled by 1008.56% to 23.22 in 2024, then sank by 733.64% to 193.57 in 2025, then jumped by 106.26% to 12.12 in 2026.
- The last three Interest Coverage Ratio figures came in at 12.12 (Q2 2026), 0.37 (Q1 2026), and 193.57 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 579.00 |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 12.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.12 |
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -193.57 |
| Sep 30, 2025 | -29.99 |
| Jun 30, 2025 | -13.34 |
| Mar 31, 2025 | -10.02 |
| Dec 31, 2024 | -23.22 |
| Sep 30, 2024 | -21.31 |
| Dec 31, 2023 | 2.56 |
| Sep 30, 2023 | -3.59 |